Anti Capital Adopts Time-Series Database QuestDB to Power Next-Generation Trading Infrastructure 
Elevating Imaging, Empowering Flow – AGFA HealthCare at RSNA 2025 Alimera Sciences Reports Fourth Quarter and 2020 Results
Fourth Quarter Highlights: Consolidated Net Revenue of $13.8 Million Up 10% vs. Third Quarter of…
GBT Reports Recent Business Progress and Fourth Quarter and Full Year 2020 Financial Results
Achieved Oxbryta® (voxelotor) net revenues of $41.3 million in the fourth quarter and $123.8 million for…
Quotient Limited to Participate in the Cowen 41st Annual Healthcare Conference
JERSEY, Channel Islands, Feb. 24, 2021 (GLOBE NEWSWIRE) — Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics…
Seer to Present at the Cowen 41st Annual Healthcare Conference
REDWOOD CITY, Calif., Feb. 24, 2021 (GLOBE NEWSWIRE) — Seer, Inc., (Nasdaq: SEER), a life…
Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2020 Financial Results
SEATTLE, Feb. 24, 2021 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a…
Paratek Pharmaceuticals Announces Full Year 2020 Total Revenue of $46.9 Million including NUZYRA® (omadacycline) Net U.S. Sales of $38.8 Million
— NUZYRA Generated Net U.S. Sales of $12.4 Million in the Fourth Quarter 2020; a…
G1 Therapeutics Provides Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights
– G1’s COSELA™ (trilaciclib) Approved by FDA as First and Only Therapy to Decrease the…
Vaxart to Provide 2021 Business Outlook on Tuesday, March 2, 2021
SOUTH SAN FRANCISCO, Calif., Feb. 24, 2021 (GLOBE NEWSWIRE) — Vaxart, Inc., a clinical-stage biotechnology…
InflaRx Announces Proposed Offering of Common Shares and One-Year Warrants
JENA, Germany, Feb. 24, 2021 (GLOBE NEWSWIRE) — InflaRx N.V. (Nasdaq: IFRX), a clinical-stage biopharmaceutical…
Inventiva to participate at several investor conferences in March 2021
Daix (France), February 24, 2021 – Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical…
Coherus BioSciences Reports Fourth Quarter and Full Year 2020 Financial Results
– Product revenues of $476 million for full year 2020, $110 million for the fourth…
BridgeBio Pharma To Announce Proof-Of-Concept Data from ADH1 at the Endocrine Society’s 2021 Annual Meeting
Company to Host Webcast to Discuss Proof-of-Concept Data for Encaleret in Autosomal Dominant Hypocalcemia Type…
Pan-Biome Pharmaceuticals, Inc reports positive results in preclinical trial of Inflammatory Bowel Disease: oral drug shows strong effect in modulating the gut microbiome
VANCOUVER, British Columbia, Feb. 24, 2021 (GLOBE NEWSWIRE) — Pan-Biome Pharmaceuticals, Inc, a Vancouver based…
LIDDS files patent application for method to treat brain cancer with intratumoral depot injections
UPPSALA, SWEDEN – LIDDS AB (publ) announced today that a patent application related to NanoZolid®…
Segra Enters Agreement Making BioAgronomics Group’s Premium Cannabis Cultivar Portfolio Available to Licensed Producers Across Canada and Select International Markets
VANCOUVER, British Columbia, Feb. 24, 2021 (GLOBE NEWSWIRE) — Segra International Corp., an AgTech firm…
AIM ImmunoTech’s Subsidiary Receives Orphan Medicinal Product Designation by the European Medicines Agency for Ampligen to Treat Pancreatic Cancer
Prof. Casper van Eijck, surgeon and a global leading expert in pancreatic cancer Prof. Casper…
Lixte Biotechnology to Present Its Anti-Cancer Therapy Enhancer LB-100 at the Virtual H.C. Wainwright Global Life Sciences Conference
LB-100 is Currently in Clinical Studies for Four Cancer Targets: Phase 1b/2 for Myelodysplastic (MDS)…
22nd Century Group Provides Business Update Letter from CEO
Global Commercial Opportunities in Approximately +$800 Billion Markets Across Tobacco and Hemp/Cannabis WILLIAMSVILLE, N.Y., Feb….
Locus Biosciences completes first-of-its-kind controlled clinical trial for CRISPR-enhanced bacteriophage therapy
Phase 1b trial demonstrates that the company’s lead precision medicine asset is safe and well…
CoImmune, Inc. Announces Appointment of Ed Baracchini to Board of Directors
DURHAM, N.C., Feb. 24, 2021 (GLOBE NEWSWIRE) — CoImmune, Inc., a clinical stage immuno-oncology company…